We provide AI‑driven automation tools for clinical research and pharmaceutical operations, embedding regulatory compliance into every workflow. Our platform streamlines data management, audit preparation, and trial monitoring, reducing manual effort while ensuring adherence to global regulatory standards.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical research and pharmaceutical operations rely heavily on manual data handling, audit preparation, and trial monitoring, which are time‑consuming and prone to errors. Ensuring compliance with complex global regulatory standards adds further operational burden, slowing study timelines and increasing costs.
Solution
Trialgenasys offers an AI‑driven automation platform that embeds regulatory compliance into every step of clinical trial workflows. The system automates data management, audit documentation, and real‑time trial monitoring, reducing manual effort while maintaining adherence to global standards. Generative AI models interpret and structure raw trial data, generate compliance reports, and flag deviations for immediate remediation. By integrating these capabilities into a unified interface, the platform accelerates study timelines and improves operational efficiency for biotech and pharmaceutical organizations.
Target Audience
Primary customers are biotech companies, pharmaceutical manufacturers, and contract research organizations that conduct regulated clinical trials and need to streamline compliance‑heavy operations.
Features
- AI‑powered data ingestion that normalizes heterogeneous clinical trial datasets into a compliant, searchable format
- Automated audit trail generation with built‑in validation against FDA, EMA, and ICH guidelines
- Real‑time monitoring dashboards that surface protocol deviations and risk indicators using predictive analytics
- Generative AI tools that draft regulatory submission documents, SOPs, and monitoring reports
- Configurable workflow automation that routes tasks, approvals, and notifications to relevant stakeholders
- Secure, cloud‑native architecture with role‑based access control and end‑to‑end encryption